Aritajati, T., Chayakul, C., & Tongyoo, S. (2022). Terlipressin for refractory septic shock: a study protocol of a single center, placebo-controlled double-blind phase III RCT (The TERESEP study). Clinical Critical Care, 30, 2022:e0003. https://doi.org/10.54205/ccc.v30.254966